Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: Impact on lymphocyte compartment composition

Leukemia Research

Volumn 35, Issue 4, 2011, Pages 484-491

  Van Tilburg, Cornelis M ^a   van der Velden, Vincent H J ^b   Sanders, Elisabeth A M ^a   Wolfs, Tom F W ^a   Gaiser, Jacobus F ^a   de Haas, Valerie ^c   Pieters, Rob ^c,d   Bloem, Andries C ^a   Bierings, Marc B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Acute lymphoblastic leukemia; B lymphocyte subsets; Child; Immunologic memory; T lymphocyte subsets; Toxicity

Indexed keywords

ANTILEUKEMIC AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GENE FREQUENCY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERMETHOD COMPARISON; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ANTIGENS, CD27; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INFANT; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952362868     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.10.005     Document Type: Article

References (42)

1. Pui C.H., Campana D., Pei D., Bowman W.P., Sandlund J.T., Kaste S.C., et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. New Engl J Med 2009, 360:2730-2741.
2. Veerman A.J., Kamps W.A., van den Berg H., van den Berg E., Bokkerink J.P., Bruin M.C., et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch childhood oncology group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 2009, 10:957-966.
3. Childhood Acute Lymphoblastic Leukaemia Collaborative Group Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5659 children. Br J Haematol 2010, 149:722-733.
4. Steele T.A. Chemotherapy-induced immunosuppression and reconstitution of immune function. Leuk Res 2002, 26:411-414.
5. Lehrnbecher T., Koehl U., Wittekindt B., Bochennek K., Tramsen L., Klingebiel T., et al. Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies. Lancet Oncol 2008, 9:269-278.
6. Eyrich M., Wiegering V., Lim A., Schrauder A., Winkler B., Schlegel P.G. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients. Br J Haematol 2009, 147:360-370.
7. van Wering E.R., van der Linden-Schrever B.E., Szczepanski T., Willemse M.J., Baars E.A., Wijngaarde-Schmitz H.M., et al. Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease. Br J Haematol 2000, 110:139-146.
8. van Lochem E.G., Wiegers Y.M., van den Beemd R., Hahlen K., van Dongen J.J., Hooijkaas H. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy. Leukemia 2000, 14:688-695.
9. Nilsson A., De Milito A., Engstrom P., Nordin M., Narita M., Grillner L., et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002, 109:e91.
10. Caver T.E., Slobod K.S., Flynn P.M., Behm F.G., Hudson M.M., Turner E.V., et al. Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia. Leukemia 1998, 12:619-622.
11. Ek T., Mellander L., Andersson B., Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 2005, 44:461-468.
12. Lehrnbecher T., Schubert R., Behl M., Koenig M., Rose M.A., Koehl U., et al. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia. Br J Haematol 2009, 147:700-705.
13. Haining W.N., Neuberg D.S., Keczkemethy H.L., Evans J.W., Rivoli S., Gelman R., et al. Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia. Blood 2005, 106:1749-1754.
14. Mazur B., Szczepanski T., Karpe J., Sonta-Jakimczyk D., Bubala H., Torbus M. Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia. Leuk Res 2006, 30:33-36.
15. van Gent R., van Tilburg C.M., Nibbelke E.E., Otto S.A., Gaiser J.F., Janssens-Korpela P.L., et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol 2009, 133:95-107.
16. Flohr T., Schrauder A., Cazzaniga G., Panzer-Grumayer R., van der Velden V., Fischer S., et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008, 22:771-782.
17. Sims G.P., Ettinger R., Shirota Y., Yarboro C.H., Illei G.G., Lipsky P.E. Identification and characterization of circulating human transitional B cells. Blood 2005, 105:4390-4398.
18. Cuss A.K., Avery D.T., Cannons J.L., Yu L.J., Nichols K.E., Shaw P.J., et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006, 176:1506-1516.
19. Klein U., Rajewsky K., Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998, 188:1679-1689.
20. Kuppers R., Klein U., Hansmann M.L., Rajewsky K. Cellular origin of human B-cell lymphomas. New Engl J Med 1999, 341:1520-1529.
21. Sanz I., Wei C., Lee F.E., Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008, 20:67-82.
22. Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994, 180:329-339.
23. -IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006, 177:3728-3736.
24. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003, 197:939-945.
25. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004, 104:3647-3654.
26. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annu Rev Immunol 2009, 27:267-285.
27. Arce E., Jackson D.G., Gill M.A., Bennett L.B., Banchereau J., Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001, 167:2361-2369.
28. Warnatz K., Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008, 74:261-271.
29. Rakhmanov M., Keller B., Gutenberger S., Foerster C., Hoenig M., Driessen G., et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U.S.A. 2009, 106:13451-13456.
30. Moir S., Ho J., Malaspina A., Wang W., DiPoto A.C., O'Shea M.A., et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008, 205:1797-1805.
31. Ehrhardt G.R., Hsu J.T., Gartland L., Leu C.M., Zhang S., Davis R.S., et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 2005, 202:783-791.
32. Wehr C., Eibel H., Masilamani M., Illges H., Schlesier M., Peter H.H., et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 2004, 113:161-171.
33. - T cell subset contains specialized primed T cells. J Immunol 1995, 154:17-25.
34. Comans-Bitter W.M., de Groot R., van den Beemd R., Neijens H.J., Hop W.C., Groeneveld K., et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997, 130:388-393.
35. - cells are induced by antigen and evolve through extensive rounds of division. Int Immunol 1999, 11:1027-1033.
36. Shearer W.T., Rosenblatt H.M., Gelman R.S., Oyomopito R., Plaeger S., Stiehm E.R., et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003, 112:973-980.
37. van den Doel L.J., Pieters R., Huismans D.R., van Zantwijk C.H., Loonen A.H., Broekema G.J., et al. Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia. Eur J Haematol 1988, 41:170-175.
38. Carsetti R., Rosado M.M., Donnanno S., Guazzi V., Soresina A., Meini A., et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005, 115:412-417.
39. van Tilburg CM, Sanders EA, Nibbelke EE, Pieters R, Revesz T, Westers P, et al. Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity. Br J Haematol, in press.
40. Roll P., Palanichamy A., Kneitz C., Dorner T., Tony H.P. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum 2006, 54:2377-2386.
41. van Tilburg C.M., Sanders E.A., Rovers M.M., Wolfs T.F., Bierings M.B. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia 2006, 20:1717-1722.
42. Patel S.R., Ortin M., Cohen B.J., Borrow R., Irving D., Sheldon J., et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 2007, 44:635-642.